Lomustine, Etoposide and Cyclophosphamide as Conditioning for Auto‐HCT in Lymphomas

20250 citationsletter

Authors

Rafaella Cabral Samico · Gerald P. Murphy Cancer Foundation

Júlia Diniz Ferreira · Universidade Federal de Juiz de Fora

Christianne Tolêdo de Souza Leal · Universidade Federal de Juiz de Fora

Kelli Borges dos Santos · Universidade Federal de Juiz de Fora

Ana C. Xavier · University of Alabama at Birmingham

Abrahão Elias Hallack Neto · Universidade Federal de Juiz de Fora

Abstract

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/hon.70122. The datasets generated during and/or analyzed during the current study are not publicly available due to the Brazilian General Data Protection Law (LGPD), which aims to protect the privacy and rights of individuals, but they are available from the corresponding author upon reasonable request.

Topics & Keywords

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders

Publication Details

Published in: Hematological Oncology

Volume 43, Issue 5, pp. e70122-e70122

DOI: 10.1002/hon.70122

Field-Weighted Citation Impact: 0.00

Command Palette

Lomustine, Etoposide and Cyclophosphamide as Conditioning for Auto‐HCT in Lymphomas

Authors

Abstract

Topics & Keywords

Publication Details